tiprankstipranks
Theralase Technologies (TSE:TLT)
:TLT
Canadian Market
Holding TSE:TLT?
Track your performance easily

Theralase Technologies (TLT) Financial Statements

82 Followers

Theralase Technologies Financial Overview

Theralase Technologies's market cap is currently ―. The company's EPS TTM is C$-0.018; its P/E ratio is ―; Theralase Technologies is scheduled to report earnings on April 23, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 346.58K$ 100.85K$ 175.55K$ 363.61K-
Gross Profit$ 200.77K$ 27.96K$ 62.11K$ 219.32K-
EBIT--$ -1.26M$ -3.55M-
EBITDA--$ -1.19M$ -3.48M-
Net Income Common Stockholders$ -937.53K$ -1.13M$ -1.27M$ -3.56M$ -1.02M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 665.38K$ 733.59K$ 409.96K$ 317.55K$ 482.46K
Total Assets$ 3.22M$ 3.38M$ 3.25M$ 3.28M$ 3.00M
Total Debt$ 317.73K$ 341.19K$ 364.23K$ 386.88K$ 409.14K
Net Debt$ -347.65K$ -392.41K$ -45.73K$ 69.33K$ -73.33K
Total Liabilities$ 1.08M$ 1.73M$ 1.28M$ 1.37M$ 1.37M
Stockholders Equity$ 2.14M$ 1.66M$ 1.97M$ 1.91M$ 1.63M
Cash Flow-
Free Cash Flow--$ -1.10M$ -1.26M-
Operating Cash Flow$ -1.37M$ -405.51K$ -1.09M$ -1.25M$ -594.42K
Investing Cash Flow$ -8.60K$ -871.00$ -3.58K$ -11.44K$ -10.91K
Financing Cash Flow$ 1.28M$ 720.34K$ 1.17M$ 1.07M$ 433.12K
Currency in USD

Theralase Technologies Earnings and Revenue History

Theralase Technologies Debt to Assets

Theralase Technologies Cash Flow

Theralase Technologies Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis